VIM
SUPN icon

VELA Investment Management’s Supernus Pharmaceuticals SUPN Stock Holding History

VELA Investment Management’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3M Buy
64,594
+12,983
+25% +$624K 0.64% 56
2026
Q1 		$2.67M Buy
51,611
+1,701
+3% +$86.6K 0.61% 54
2025
Q4 		$2.48M Buy
49,910
+9,659
+24% +$470K 0.58% 57
2025
Q3 		$1.92M Buy
+40,251
New +$1.62M 0.47% 71

Other funds holding SUPN

SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
PFC
Phocas Financial Corp Alameda, California $721M AUM 63.77% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

VELA Investment Management's SUPN Position: Q2 2026 in Review

VELA Investment Management increased its Supernus Pharmaceuticals (SUPN) stake by 25% in Q2 2026, buying an estimated $624K and bringing the position to 64,594 shares worth $3M. The position accounts for 0.64% of the portfolio, ranked #56.

VELA Investment Management first reported a position in SUPN in Q3 2025 and has held it in 4 quarters since. 87 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

  • VELA Investment Management held 64,594 shares of Supernus Pharmaceuticals worth $3M as of Q2 2026.
  • VELA Investment Management bought 12,983 Supernus Pharmaceuticals shares in Q2 2026, an estimated $624K.
  • Supernus Pharmaceuticals made up 0.64% of VELA Investment Management's portfolio in Q2 2026, its #56 holding.
  • VELA Investment Management first reported a position in Supernus Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 87 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on VELA Investment Management's 13F filing for Q2 2026, filed 3 Aug 2026.